Latest Period
Q4 2025
- Info
- Insider Trading
- Financials
- Holders
Security Snapshot
PROKIDNEY CORP. - Class A Common Stock (PROK) Institutional Ownership
CUSIP: 74291D104
13F Institutional Holders and Ownership History from Q2 2025 to Q1 2026
Institutions Reporting
61
Shares (Excl. Options)
41,944,849
Price
$2.24
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / Class A Common Stock
- Symbol
- PROK on Nasdaq
- Shares outstanding
- 141,999,700
- Price per share
- $1.39
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 41,944,849
- Total reported value
- $93,956,490
- % of total 13F portfolios
- 0%
- Share change
- +8,493,675
- Value change
- +$18,974,610
- Number of holders
- 61
- Price from insider filings
- $1.39
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- PROK - PROKIDNEY CORP. - Class A Common Stock is tracked under CUSIP 74291D104.
- 61 institutions reported positions in Q4 2025.
- 1 significant owner is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 61 to 2 between Q4 2025 and Q1 2026.
- Reported value moved from $93,956,490 to $1,134.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 61 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 74291D104?
CUSIP 74291D104 identifies PROK - PROKIDNEY CORP. - Class A Common Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 74291D104:
Significant Owners of PROKIDNEY CORP. - Class A Common Stock (PROK) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| MORGAN STANLEY | 6% | $19,510,759 | 8,519,982 | Morgan Stanley | 31 Dec 2025 |
As of 31 Dec 2025, 61 institutional investors reported holding 41,944,849 shares of PROKIDNEY CORP. - Class A Common Stock (PROK). This represents 30% of the company’s total 141,999,700 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of PROKIDNEY CORP. - Class A Common Stock (PROK) together control 29% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 8.7% | 12,341,266 | 0% | 0.69% | $27,644,436 |
| MORGAN STANLEY | 6.2% | 8,817,001 | +31% | 0% | $19,750,082 |
| Bleichroeder LP | 1.4% | 2,000,000 | 0% | 0.79% | $4,480,000 |
| Artia Global Partners LP | 1.3% | 1,838,411 | 0.66% | $4,118,041 | |
| MILLENNIUM MANAGEMENT LLC | 1.3% | 1,834,536 | -6.2% | 0% | $4,109,361 |
| VANGUARD GROUP INC | 1.2% | 1,648,229 | +5.4% | 0% | $3,692,033 |
| Hennion & Walsh Asset Management, Inc. | 1.1% | 1,503,886 | +63% | 0.12% | $3,368,705 |
| BlackRock, Inc. | 0.99% | 1,404,167 | +9.9% | 0% | $3,145,334 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.84% | 1,197,530 | +9.2% | 0% | $2,683,540 |
| RENAISSANCE TECHNOLOGIES LLC | 0.63% | 895,705 | +579% | 0% | $2,006,379 |
| BANK OF AMERICA CORP /DE/ | 0.5% | 706,144 | +6.9% | 0% | $1,581,763 |
| GOLDMAN SACHS GROUP INC | 0.48% | 681,161 | +314% | 0% | $1,525,801 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.44% | 623,110 | -4.6% | 0% | $1,395,766 |
| MARSHALL WACE, LLP | 0.43% | 612,485 | +654% | 0% | $1,371,967 |
| Woodline Partners LP | 0.35% | 500,000 | 0% | $1,120,000 | |
| JANE STREET GROUP, LLC | 0.35% | 493,849 | +616% | 0% | $1,106,222 |
| STATE STREET CORP | 0.34% | 480,345 | +1.1% | 0% | $1,075,973 |
| TWO SIGMA INVESTMENTS, LP | 0.33% | 465,509 | +369% | 0% | $1,042,740 |
| MYDA Advisors LLC | 0.31% | 440,000 | -2.2% | 0.28% | $985,600 |
| UBS Group AG | 0.29% | 416,539 | -18% | 0% | $933,047 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.28% | 398,880 | +56% | 0% | $893,491 |
| CITADEL ADVISORS LLC | 0.26% | 371,797 | +7.8% | 0% | $832,825 |
| Squarepoint Ops LLC | 0.25% | 351,421 | +2% | 0% | $787,183 |
| Amundi | 0.19% | 272,242 | 0% | $609,822 | |
| NORTHERN TRUST CORP | 0.17% | 241,580 | +27% | 0% | $541,139 |